Baldness reversed by chemotherapy - 24/04/13
Funding sources: None. |
|
Conflicts of interest: The clinical trial mentioned in this report was sponsored by Aventis, the maker of docetaxel. Dr Read participated as an investigator in a subsequent clinical trial (now closed) of docetaxel in head and neck cancer, which was also sponsored by Aventis. Dr Read has no other relevant financial disclosures. |
Vol 63 - N° 4
P. 727-728 - octobre 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?